EVIDENCE BASED SELECTION OF PATIENTS FOR CLINICAL TRIALS USING HISTOPATHOLOGY

摘要

An immune gene expression signature and immune cell distribution in the tumor, in combination, can be used to infer an immune phenotype of the tumor, which further can be used to characterize the tumor, selecting an optimal immune therapy to the tumor, and predicting the treatment outcome of an immune therapy.